Literature DB >> 10509534

Secondary brain tumours in children with ALL.

M Stanulla, L Löning, K Welte, M Schrappe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10509534     DOI: 10.1016/S0140-6736(05)76923-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  The thiopurines: an update.

Authors:  Sally Coulthard; Linda Hogarth
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

2.  Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.

Authors:  Kjeld Schmiegelow; Ibrahim Al-Modhwahi; Mette Klarskov Andersen; Mikael Behrendtz; Erik Forestier; Henrik Hasle; Mats Heyman; Jon Kristinsson; Jacob Nersting; Randi Nygaard; Anne Louise Svendsen; Kim Vettenranta; Richard Weinshilboum
Journal:  Blood       Date:  2009-02-17       Impact factor: 22.113

3.  Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia-A population-based analysis of the Austrian ALL-BFM Study Group.

Authors:  Fiona Poyer; Karin Dieckmann; Michael Dworzak; Melanie Tamesberger; Oskar Haas; Neil Jones; Karin Nebral; Stefan Köhrer; Reinhard Moser; Gabriele Kropshofer; Christina Peters; Christian Urban; Georg Mann; Ulrike Pötschger; Andishe Attarbaschi
Journal:  EJHaem       Date:  2022-06-12

4.  Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers.

Authors:  Rohit P Ojha; Joseph E Tota; Tabatha N Offutt-Powell; James L Klosky; Timothy D Minniear; Bradford E Jackson; James G Gurney
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.